Takeda Pharma and Shire Come Back to the Negotiating Table
Takeda Pharmaceutical has come back with an improved bid for Shire, making it the fifth round of talks.
The Home of the Life Sciences Industry
Explore Latest News
Biogen’s First Quarter Driven by MS Drugs and Spinraza
Biogen saw a strong first quarter with 11 percent growth in revenues to $3.1 billion, which were spurred by gains in spinal muscular atrophy (SMA) treatment Spinraza and multiple sclerosis treatment Tecfidera.
- Companies Showcase Good News for Patients at AAN
- Eli Lilly’s Arthritis Drug Gets Mixed Recommendation, But Reports Strong Quarter
- Cedilla Therapeutics Launches with $56.2 Million
- Knowledge Ecology International (KEI) Sues NIH Over Gilead CAR-T Patents
- Orexigen Enters into Agreement to Sell Company to Newly Formed Entity Nalpropion Pharmaceuticals
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.